SANDOZ A/S: Financial statements 2013
CVR: 27744532
Source: annual report 2013, Danish Business Authority
01/01/2013 – 31/12/2013
SANDOZ A/S (CVR 27744532) has filed annual accounts for 2013. In 2013, the company reported revenue of DKK 1,067,413,440 and a net result of DKK 25,209,040. The profit margin was 2.4%. Equity in the 2013 report amounted to DKK 453,132,006. The solvency ratio was 63.9%. The company had 65 employees in the financial year.
- Revenue
- DKK 1,067,413,440
- Gross Profit
- DKK 202,363,848
- Profit/Loss
- DKK 25,209,040
- Equity
- DKK 453,132,006
- Total Assets
- DKK 708,910,819
- Employees
- 65
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2013
SANDOZ A/S has published its annual report for 2012.
About SANDOZ A/S
SANDOZ A/S is a Danish company of the type Aktieselskab based in København S, founded in 2004. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named DURASCAN MEDICAL PRODUCTS A/S. The management consists of Lawrence Edward Mead. The board consists of Diane Marie DiGangi (chair), Lawrence Edward Mead and Nete Brændgaard. The company is owned by Sandoz AG. The company has 119 employees (2026). In 2025, the company reported revenue of DKK 2,515,342,000 and a net result of DKK 85,168,000 compared with DKK 48,047,000 the year before. Equity in the 2025 report amounted to DKK 662,792,000.